Literature DB >> 33414762

Low Contrast Visual Acuity Might Help to Detect Previous Optic Neuritis.

Soo-Hyun Park1, Choul Yong Park2, Young Joo Shin3, Kyoung Sook Jeong4, Nam-Hee Kim5.   

Abstract

Optic neuritis (ON) has been considered to be an important factor in the diagnosis of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), making ON detection increasingly critical for early diagnosis. Furthermore, subclinical ONs presenting no distinct decrease in visual acuity can be missed. Low contrast visual acuity (LC-VA) is known to be able to capture visual loss not seen in conventional high-contrast visual acuity (HC-VA) in MS. Therefore, to increase the sensitivity of ON detection, we investigated the advantage of LC-VA over conventional HC-VA. One hundred and eight patients with demyelinating disease (35 MS, 73 NMOSD) with ON at least 3 months prior and 35 controls underwent neuro-ophthalmic evaluation, including best-corrected conventional high contrast visual acuity (HC-VA) and 2.5% and 1.25% low contrast visual acuity (LC-VA). Receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC) of various visual functions were used to determine the most relevant visual function test for the detection of optic nerve involvement. Additionally, the optimal cutoff point was obtained from the Youden index (J-index) as the points with the best sensitivity-specificity balance. When distinguishing ON from non-ON, the area under the ROC curve (AUC) was highest for the 2.5% LC-VA (0.835, P < 0.001; sensitivity 71.5%, specificity 88.6%), while it was 0.710 (P < 0.001) for the HC-VA and 0.770 (P < 0.001) for the 1.25% LC-VA. In discriminating between controls and ON, the AUC was also highest for the 2.5% LC-VA 0.754 (P < 0.001; sensitivity 71.5%, specificity 78.5%), while it was 0.719 (P < 0.001) for HC-VA and 0.688 (P < 0.001) for 1.25% LC-VA. In eyes with a history of ON (n = 137), the HC-VA and 2.5% LC-VA were abnormal in 64.2 and 71.5%, respectively (P < 0.001), with their combination detecting abnormalities in approximately 85.4% (P < 0.001). The 2.5% LC-VA was superior to HC-VA in detecting ON when distinguishing ON from non-ON or control. The 2.5% LC-VA might be a useful, feasible, and rapid method to detect ON. Furthermore, combining 2.5% LC-VA with conventional HC-VA would be better for detecting optic nerve involvements.
Copyright © 2020 Park, Park, Shin, Jeong and Kim.

Entities:  

Keywords:  low contrast visual acuity; multiple sclerosis; neuromyelitis optica spectrum disorder; optic neuritis; visual acuity

Year:  2020        PMID: 33414762      PMCID: PMC7783398          DOI: 10.3389/fneur.2020.602193

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  27 in total

1.  Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.

Authors:  Laura J Balcer; Steven L Galetta; Chris H Polman; Eric Eggenberger; Peter A Calabresi; Annie Zhang; James V Scanlon; Robert Hyde
Journal:  J Neurol Sci       Date:  2012-04-21       Impact factor: 3.181

2.  Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis.

Authors:  D Regan; J Raymond; A P Ginsburg; T J Murray
Journal:  Brain       Date:  1981-06       Impact factor: 13.501

3.  Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.

Authors:  Elke Voss; Peter Raab; Corinna Trebst; Martin Stangel
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

4.  Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.

Authors:  Erin E Longbrake; Samantha Lancia; Nhial Tutlam; Kathryn Trinkaus; Robert T Naismith
Journal:  Mult Scler Relat Disord       Date:  2016-11-04       Impact factor: 4.339

Review 5.  Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

Authors:  Scott S Zamvil; Anthony J Slavin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-01-22

6.  Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.

Authors:  Marta Owidzka; Michal Wilczynski; Wojciech Omulecki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-28       Impact factor: 3.117

7.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.

Authors:  Florence Pache; Hanna Zimmermann; Janine Mikolajczak; Sophie Schumacher; Anna Lacheta; Frederike C Oertel; Judith Bellmann-Strobl; Sven Jarius; Brigitte Wildemann; Markus Reindl; Amy Waldman; Kerstin Soelberg; Nasrin Asgari; Marius Ringelstein; Orhan Aktas; Nikolai Gross; Mathias Buttmann; Thomas Ach; Klemens Ruprecht; Friedemann Paul; Alexander U Brandt
Journal:  J Neuroinflammation       Date:  2016-11-01       Impact factor: 8.322

Review 8.  Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.

Authors:  Laura J Balcer; Jenelle Raynowska; Rachel Nolan; Steven L Galetta; Raju Kapoor; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

9.  Optic neuritis, its differential diagnosis and management.

Authors:  Hedieh Hoorbakht; Farid Bagherkashi
Journal:  Open Ophthalmol J       Date:  2012-07-24

10.  Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis.

Authors:  Lisanne J Balk; Danko Coric; Jenny A Nij Bijvank; Joep Killestein; Bernard Mj Uitdehaag; Axel Petzold
Journal:  Mult Scler       Date:  2017-05-17       Impact factor: 6.312

View more
  4 in total

1.  Isobaric Incorporation of C13-Histidine for the Assessment of Remyelination.

Authors:  Faith Christine Harvey; Anddre Osmar Valdivia; Colin Hayter; Sanjoy K Bhattacharya
Journal:  Methods Mol Biol       Date:  2023

2.  Low-Contrast High-Pass Visual Acuity Might Help to Detect Glaucoma Damage: A Structure-Function Analysis.

Authors:  Yun Wen; Zidong Chen; Chengguo Zuo; Yangfan Yang; Jiangang Xu; Yang Kong; Hui Cheng; Minbin Yu
Journal:  Front Med (Lausanne)       Date:  2021-05-14

3.  Lyso-Lipid-Induced Oligodendrocyte Maturation Underlies Restoration of Optic Nerve Function.

Authors:  Anddre Osmar Valdivia; Sanjoy K Bhattacharya
Journal:  eNeuro       Date:  2022-01-26

4.  Low Contrast Visual Evoked Potentials for Early Detection of Optic Neuritis.

Authors:  Soo-Hyun Park; Choul-Yong Park; Young Joo Shin; Kyoung Sook Jeong; Nam-Hee Kim
Journal:  Front Neurol       Date:  2022-04-29       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.